Science Explorer Back to mapMap
Discussion
Company · Lausanne · Switzerland

Amazentis (Switzerland)

amazentis.comROR OpenAlex
Research works
10
▼ 3% vs 2018-21
Citations
1.5k
152.3 per fractional work
Top-10% rate
65.5%
all institutions 10.0%
Open access
85%
world 40%
International
42%
world 18%
Amazentis (Switzerland)

Not ranked overall: Amazentis (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Amazentis (Switzerland) work in?

In all years, 67% of research at Amazentis (Switzerland) is in Health Sciences, 31% in Life Sciences. Its largest fields are Medicine (36%), Nursing (31%), Agricultural and Biological Sciences (16%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 7 fractional works · 67.1% of its workMedicine: 4 fractional works · 36.2% of its workBiochemistry: 2 fractional works · 20.1% of its workPhysiology: 1 fractional works · 5.6% of its workComplementary and alternative medicine: 1 fractional works · 5.2% of its workGeriatrics and Gerontology: 0 fractional works · 1.8% of its workEpidemiology: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.8% of its workRheumatology: 0 fractional works · 0.6% of its workRehabilitation: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workNursing: 3 fractional works · 30.9% of its workNutrition and Dietetics: 3 fractional works · 30.9% of its workLife Sciences: 3 fractional works · 30.8% of its workAgricultural and Biological Sciences: 2 fractional works · 15.7% of its workPlant Science: 1 fractional works · 12.3% of its workInsect Science: 0 fractional works · 3.4% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 14.6% of its workClinical Biochemistry: 1 fractional works · 7.0% of its workMolecular Biology: 0 fractional works · 4.4% of its workAging: 0 fractional works · 1.7% of its workPhysiology: 0 fractional works · 1.1% of its workCancer Research: 0 fractional works · 0.5% of its workNeuroscience: 0 fractional works · 0.5% of its workDevelopmental Neuroscience: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 1.3% of its workBusiness, Management and Accounting: 0 fractional works · 1.3% of its workManagement Information Systems: 0 fractional works · 0.7% of its workStrategy and Management: 0 fractional works · 0.7% of its workPhysical Sciences: 0 fractional works · 0.7% of its workEngineering: 0 fractional works · 0.7% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.7% of its workALL ITS WORKAmazentis(Switzerland)10fractional works, all years
Life Sciences31%Physical Sciences1%Health Sciences67%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 7 fields, with their numbers
    1. Medicine436.2%
    2. Nursing330.9%
    1. Agricultural and Biological Sciences215.7%
    2. Biochemistry, Genetics and Molecular Biology114.6%
    3. Neuroscience00.5%
    1. Business, Management and Accounting01.3%
    1. Engineering00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 3.06× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.13× its world share, 1 worksBiochemistry, Geneti…Neuroscience: 0.71× its world share, 0 worksNeuroscienceEngineering: 0.11× its world share, 0 worksEngineeringMedicine: 1.50× its world share, 1 worksMedicineNursing: 58.37× its world share, 1 worksNursingBusiness, Management and Accounting: 1.00× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 58.4×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Nursing58.37×1 works
  2. Biochemistry, Genetics and Molecular Biology4.13×1 works
  3. Agricultural and Biological Sciences3.06×1 works
  4. Medicine1.50×1 works
  5. Business, Management and Accounting1.00×0 works
  6. Neuroscience0.71×0 works
  7. Engineering0.11×0 works

Who are the top researchers at Amazentis (Switzerland)?

Ranked on the quality score, Anurag Singh lead among researchers whose main affiliation is Amazentis (Switzerland).

  1. 1 Anurag Singh Switzerland · #421,152 worldwide 2.1k citations · 24 works
All ranked researchers at Amazentis (Switzerland)

What are the most cited papers from Amazentis (Switzerland)?

The most cited paper from Amazentis (Switzerland) is "The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity" (Carles Cantó, Riekelt H. Houtkooper, Eija Pirinen et al., 2012), with 1,262 citations. Next come "Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents" (1,116) and "Mitophagy in human health, ageing and disease" (605).

Most cited papers
#PaperReleasedCitations
1 The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity Carles Cantó, Riekelt H. Houtkooper, Eija Pirinen et al. · Cell Metabolism Open access Jun 2012 1,262
2 Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents Dongryeol Ryu, Laurent Mouchiroud, Pénélope A. Andreux et al. · Nature Medicine Open access 11 Jul 2016 1,116
3 Mitophagy in human health, ageing and disease Anna Picca, Julie Faitg, Johan H. Auwerx et al. · Nature Metabolism Open access 30 Nov 2023 605
4 The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans Pénélope A. Andreux, William E. Blanco-Bose, Dongryeol Ryu et al. · Nature Metabolism Open access 14 Jun 2019 582
5 Impact of the Natural Compound Urolithin A on Health, Disease, and Aging Davide Francesco D'Amico, Pénélope A. Andreux, Pamela Valdés et al. · Trends in Molecular Medicine ReviewOpen access 21 May 2021 417
All 30 most cited papers, with filters and sorting

Which research topics does Amazentis (Switzerland) publish most on?

By volume in 2022-now: Pomegranate: compositions and health benefits, Paraoxonase enzyme and polymorphisms, Antioxidant Activity and Oxidative Stress and Bee Products Chemical Analysis.

Pomegranate: composition…1Pomegranate: compositions and health benefits: 1 fractional worksParaoxonase enzyme and polymorphisms: 1 fractional worksAntioxidant Activity and Oxidative Stress: 0 fractional worksBee Products Chemical Analysis: 0 fractional worksBioactive Compounds in P…0Bioactive Compounds in Plants: 0 fractional worksGinkgo biloba and Cashew Applications: 0 fractional worksMedicinal Plant Extracts Effects: 0 fractional worksAutophagy in Disease and Therapy: 0 fractional worksManagement and Optimization Techniques: 0 fractional worksSesame and Sesamin Research: 0 fractional works
Nutrition and DieteticsClinical BiochemistryBiochemistryInsect Science4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pomegranate: compositions and health benefits Nutrition and Dietetics 1 works
  2. 2 Paraoxonase enzyme and polymorphisms Clinical Biochemistry 1 works
  3. 3 Antioxidant Activity and Oxidative Stress Biochemistry 0 works
  4. 4 Bee Products Chemical Analysis Insect Science 0 works
  5. 5 Bioactive Compounds in Plants Plant Science 0 works
  6. 6 Ginkgo biloba and Cashew Applications Complementary and alternative medicine 0 works
  7. 7 Medicinal Plant Extracts Effects Complementary and alternative medicine 0 works
  8. 8 Autophagy in Disease and Therapy Epidemiology 0 works
  9. 9 Management and Optimization Techniques Strategy and Management 0 works
  10. 10 Sesame and Sesamin Research Plant Science 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available85.3%not open14.7%

World: 40% of research is openly available.

with international co-authors42.4%domestic only57.6%

World: 18% is written across borders.

How has Amazentis (Switzerland)'s research output changed?

Output in 2022-2025 was 3% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Amazentis (Switzerland) as a percentage of every work published that year, 0.0000036% in 2024.

still counting0.000020%0.000040%Amazentis (Switzerland)0.000018% in 20252020

Fractional works of Amazentis (Switzerland) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lausanne

All research institutions in Lausanne

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Amazentis (Switzerland). Posts are plain text and can be reported.